Direct oral anticoagulants for electrical cardioversion

Direct oral anticoagulants for electrical cardioversion

The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using direct oral anticoagulants for this purpose i...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. N. Volovchenko, D. A. Andreev, D. F. Mesitskaya
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-07-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation electrical cardioversion anticoagulant therapy direct oral anticoagulants
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2939
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation
by: Alan Poggio, et al.
Published: (2025-06-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin
by: Kyeong‐Hyeon Chun, et al.
Published: (2024-08-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2024-10-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Impact on Adherence and Clinical Outcomes of an Anticoagulation Stewardship Program in Users of Direct Oral Anticoagulants
by: Mayra A. Arenas-Beltrán, et al.
Published: (2025-04-01)

Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
by: E. A. Naryshkina, et al.
Published: (2025-06-01)

Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
by: S. R. Gilyarevsky, et al.
Published: (2023-07-01)

Potential for anticoagulant therapy in the most vulnerable groups of patients
by: Irina A. Zolotovskaya, et al.
Published: (2022-02-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
by: E. I. Baranova, et al.
Published: (2020-02-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

State and adequacy of anticoagulant therapy in fibrillation of precurities in clinical practice
by: A. A. Tuchkov, et al.
Published: (2021-06-01)

Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation
by: S. V. Malchikova, et al.
Published: (2020-08-01)

Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: V. I. Petrov, et al.
Published: (2019-09-01)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01)

Anticoagulant therapy in patients with atrial fibrillation and an implanted cardiac resynchronization therapy device
by: M. A. Kirgizova, et al.
Published: (2021-05-01)

Investigation of predictive parameters for recurrence in patients undergoing electrical cardioversion for atrial fibrillation
by: Levent Pay, et al.
Published: (2025-04-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Anticoagulant therapy control in primary healthcare setting
by: Z. K. Salpagarova, et al.
Published: (2016-06-01)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016-09-01)

Ischemic Stroke in Patients Under Oral Anticoagulation: The Achilles Heel of Atrial Fibrillation Management
by: Kyriakos Dimitriadis, et al.
Published: (2025-04-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion.
by: K. А. Pysarevska
Published: (2016-03-01)

Takotsubo syndrome in a patient with atrial fibrillation after electrical cardioversion: a case report
by: E. S. Sitkova, et al.
Published: (2022-12-01)

Value of transoesophageal echocardiography-guided approach to electrical cardioversion of atrial fibrillation
by: O. S. Kalashnikovа
Published: (2013-06-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Safety of oral anticoagulants: focus on cerebral microbleeds
by: M. S. Chernyaeva, et al.
Published: (2025-05-01)

The Effect of Direct Anticoagulant Therapy on Haematological Parameters in Atrial Fibrillation: Clinical Significance of Subclinical Haemoglobin Decrease
by: Metin Çoksevim, et al.
Published: (2024-11-01)

Model for predicting long-term sinus rhythm retention after electrical cardioversion in patients with persistent atrial fibrillation.
by: K. O. Pysarevska, et al.
Published: (2017-12-01)

Anticoagulation Strategies for Atrial Fibrillation in CKD Stage G5 and Dialysis Patients: An Updated Scoping Review
by: Heitor Martins de Oliveira, et al.
Published: (2025-03-01)

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01)

THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE
by: I. S. Daaboul, et al.
Published: (2018-07-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)

Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation
by: Ya-Tong Zhang, et al.
Published: (2025-04-01)

Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
by: Xiaoxi Yao, et al.
Published: (2024-07-01)

Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with liver disease: a systematic review and meta-analysis
by: Qiang Zhou, et al.
Published: (2025-07-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

Oral anticoagulation in patients with hypertrophic cardiomyopathy and non‐valvular atrial fibrillation in Japan
by: Hiroaki Kitaoka, et al.
Published: (2025-02-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)